Bhattacharya said he's "convinced" vaccines don't cause autism, but wouldn't rule out more studies on the issue.March 5, 2025Check out STAT+Sponsored By SAUL LOEB/AFP via Getty Images STAT+ | Even critics of the scientific establishment give Trump's drama-filled weeks mixed reviews STAT interviews two dozen scientists and researchers who support some of Trump's aims and finds reservations about a "chaotic, haphazard" approach. By Jason Mast Judge issues preliminary injunction blocking Trump cuts to NIH research overhead payments Nationwide injunction suggests plaintiffs seeking to overturn the sweeping policy change — a 15% cap on NIH indirect costs — likely to prevail By Jonathan Wosen NIH nominee is 'convinced' vaccines don't cause autism, but won't rule out more studies on the issue Sen. Bill Cassidy pressed Jay Bhattacharya over his refusal to rule out spending scarce NIH money on more studies of disproven link to autism By Andrew Joseph Scott Olson/Getty Images STAT+ | Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price The move follows a similar one by Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies. By Elaine Chen Cancellation of NIH summer internships disrupts 'vital' training program for U.S. scientists 'Science is in the crosshairs,' experts say. Aspiring researchers lose learning opportunity, putting future of U.S. medical innovation at risk By Usha Lee McFarling CDC invites back about 180 fired employees, including some who help fight outbreaks The CDC is the latest federal agency trying to coax back workers soon after they were dismissed as part of a cost-cutting purge. By Associated Press Adobe 'Simply good science': Women's health research reveals clues to aging and Alzheimer's A special issue of Science focuses on women's health, including links between estrogen and dementia, even as gender studies are under attack. By Elizabeth Cooney Trump administration moves to drop Idaho emergency abortion case with national implications The Justice Department filed a motion to dismiss the lawsuit, which was originally filed by the Biden administration. By Associated Press Opinion: Global freeloading: Americans shouldn't bear the brunt of drug development costs Other countries enjoy the benefits of American drug innovations, without paying the necessary costs to develop them. By Bobby Jindal and Charlie Katebi More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments